Adimab
Lebanon, United States · Founded 2007 · $26.0M raised
- Headquarters
- Lebanon, New Hampshire
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- adimab.com
- Total Funding
- $26.0M
- Last Round
- $13.8M Series FJan 2012
- Rounds
- 6
About
Provides antibody discovery and engineering services to biopharma partners using a yeast-based platform to deliver therapeutic antibodies and protein modalities.
Summary
Adimab is an Antibody Discovery company based in Lebanon, United States, founded in 2007. It has raised $26.0M in total across 6 rounds, most recently a $13.8M Series F round in Jan 2012. Investors include GV, Polaris Capital and SV Life Sciences.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2012
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...